GILD
Gilead Sciences Inc
NASDAQ: GILD · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$130.84
+1.55% today
Updated 2026-04-29
Market cap
$159.92B
P/E ratio
19.00
P/S ratio
5.43x
EPS (TTM)
$6.78
Dividend yield
2.44%
52W range
$93 – $156
Volume
6.1M
Gilead Sciences Inc (GILD) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.03B | $4.23B | $5.34B | $7.01B | $7.95B | $8.39B | $9.70B | $11.20B | $24.89B | $32.64B | $30.39B | $26.11B | $22.13B | $22.45B | $24.69B | $27.30B | $27.28B | $27.12B | $28.75B | $29.44B |
| Revenue growth (YoY) | — | +39.8% | +26.1% | +31.4% | +13.4% | +5.5% | +15.7% | +15.5% | +122.2% | +31.1% | -6.9% | -14.1% | -15.2% | +1.5% | +10.0% | +10.6% | -0.1% | -0.6% | +6.0% | +2.4% |
| Cost of revenue | $433.32M | $768.77M | $1.13B | $1.60B | $1.87B | $2.12B | $2.47B | $2.86B | $3.79B | $4.01B | $4.26B | $4.37B | $4.85B | $4.67B | $4.57B | $6.60B | $5.66B | $5.80B | $6.25B | $3.92B |
| Gross profit | $2.59B | $3.46B | $4.21B | $5.42B | $6.08B | $6.26B | $7.23B | $8.34B | $21.10B | $28.63B | $26.13B | $21.74B | $17.27B | $17.77B | $20.12B | $20.70B | $21.62B | $27.12B | $22.50B | $25.52B |
| Gross margin | 85.7% | 81.8% | 78.9% | 77.2% | 76.5% | 74.7% | 74.5% | 74.5% | 84.8% | 87.7% | 86.0% | 83.3% | 78.1% | 79.2% | 81.5% | 75.8% | 79.3% | 100.0% | 78.3% | 86.7% |
| R&D | $383.86M | $591.03M | $721.77M | $939.92M | $1.07B | $1.23B | $1.76B | $2.12B | $2.85B | $3.01B | $5.10B | $3.73B | $3.92B | $4.05B | $5.04B | $4.60B | $4.98B | $5.72B | $5.91B | $5.69B |
| SG&A | $573.66M | $705.74M | $797.34M | $946.69M | $1.04B | $1.24B | $1.46B | $1.70B | $2.98B | $3.43B | $3.40B | $3.88B | $4.06B | $3.60B | $4.32B | $4.51B | $4.89B | $6.50B | $2.64B | $5.71B |
| Operating income | $-758.75M | $2.16B | $2.68B | $3.53B | $3.96B | $3.79B | $4.01B | $4.52B | $15.27B | $22.19B | $17.63B | $14.12B | $8.20B | $4.29B | $4.07B | $9.92B | $7.33B | $7.61B | $1.66B | $11.82B |
| Operating margin | -25.1% | 51.2% | 50.2% | 50.3% | 49.8% | 45.2% | 41.3% | 40.4% | 61.3% | 68.0% | 58.0% | 54.1% | 37.1% | 19.1% | 16.5% | 36.3% | 26.9% | 28.0% | 5.8% | 40.1% |
| EBITDA | $1.68B | $2.22B | $2.89B | $3.78B | $4.29B | $4.16B | $4.25B | $4.86B | $16.32B | $23.45B | $19.22B | $15.93B | $10.30B | $7.56B | $4.13B | $11.33B | $8.85B | $7.61B | $4.43B | $10.82B |
| EBITDA margin | 55.6% | 52.4% | 54.2% | 54.0% | 53.9% | 49.6% | 43.8% | 43.4% | 65.6% | 71.8% | 63.2% | 61.0% | 46.6% | 33.7% | 16.7% | 41.5% | 32.4% | 28.0% | 15.4% | 36.7% |
| EBIT | $1.64B | $2.16B | $2.74B | $3.57B | $4.02B | $3.86B | $3.97B | $4.51B | $15.27B | $22.35B | $18.06B | $14.65B | $8.88B | $6.16B | $2.65B | $9.28B | $6.75B | $7.61B | $1.67B | — |
| Interest expense | $4.67B | $105.83M | $65.24M | $69.66M | $108.96M | $205.42M | $361.00M | $307.00M | $412.00M | $688.00M | $964.00M | $1.12B | $1.08B | $995.00M | $984.00M | $1.00B | $935.00M | $944.00M | $977.00M | $1.02B |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-1.19B | $1.62B | $1.98B | $2.64B | $2.90B | $2.80B | $2.59B | $3.08B | $12.10B | $18.11B | $13.50B | $4.63B | $5.46B | $5.39B | $123.00M | $6.22B | $4.59B | $5.67B | $480.00M | $8.51B |
| Net income growth (YoY) | — | +235.7% | +22.5% | +33.2% | +10.1% | -3.4% | -7.5% | +18.6% | +293.5% | +49.6% | -25.4% | -65.7% | +17.9% | -1.3% | -97.7% | +4961.0% | -26.2% | +23.4% | -91.5% | +1672.9% |
| Profit margin | -39.3% | 38.2% | 37.1% | 37.6% | 36.5% | 33.4% | 26.7% | 27.5% | 48.6% | 55.5% | 44.4% | 17.7% | 24.7% | 24.0% | 0.5% | 22.8% | 16.8% | 20.9% | 1.7% | 28.9% |